ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1766

Increased Renal Damage in Hypocomplementemic Patients with ANCA- Associated Vasculitis

Lucila García1, Claudia Elizabeth Pena2, Mariana Pera3, Mercedes Garcia2, Valeria Arturi3, Viviana Nagua1, Rodrigo Aguila Maldonado2, Ana Carolina Costi2, Adriana Testi1, Ariel Vulcano1, Pierina Sansinanea1, Martin Mamberti4, Maria Elena Bruzzone4, Carolina Barabani4 and Jimena Salomone4, 1Rheumatology, HIGA General San Martin La Plata, la plata, Argentina, 2Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 3HIGA General San Martin La Plata, la plata, Argentina, 4Nephrology, HIGA General San Martin La Plata, la plata, Argentina

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: complement deficiency, renal disease and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Vasculitis Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The pauci-immune nature of typical lesions in ANCA associated vasculitis (AAV) has led to the belief that complement does not play a role in the pathogenesis of this disease. Activation of the alternative complement pathway is necessary for the development of glomerulonephritis in murine models. The complement deposition in renal biopsies of patients with AAV was correlated with increased renal damage.

We hypothesized that there is greater morbidity, mortality and worse renal outcomes in hypocomplementemic patients with AAV compared to those who have normal complement values at the onset of the disease.

Our purpose was to compare clinical manifestations, laboratory values, histological type, renal prognosis and mortality in normal and hypocomplementemic patients with AAV.

Methods: Retrospective, observational, analytical study. Data from the medical records of patients over the age of 18 were evaluated between the years 2000-2017. Patients with diagnosis of AAV who met the criteria of ACR 1990 Classification or Chapel Hill Concensus Conference 2012 were included. Hypocomplementemia was defined as C3 values below 80 mg/dl or C4 below 15 mg/dl. Chi-square or Fisher’s exact test was used for dichotomous variables as appropriate. P-value <0.05 was considered statistically significant. Logistic regression analysis was used to identify predictors of survival.

Results: We analyzed 87 patients with AAV (female 56.2%, mean follow-up 24 months, mean age at onset of the disease 49 years ± 14.9 SD). Most frequent type of vasculitis was Granulomatosis with polyangeitis (49.4%).

Hypocomplementemia was determined in 7/57 patients (12.28%) and was significantly associated with renal damage (p: 0.034 OR 12.8 CI95% 0.69-236) particularly with decreased glomerular filtrate (p: 0.045 OR: 8.2 CI 95% 0.92-74.0). A higher prevalence of proteinuria greater than 1 gr/24 hs was observed in hypocomplementemic patients 57% vs 25% (p: 0.068).

All renal biopsies were classified as pauci-immune glomerulonephritis. Average number of glomeruli affected was 13 [IQR 25-75% (7-17)], predominating the sclerosing type (44%). The degree of interstitial fibrosis, tubular atrophy (52%) and vascular damage (57%) was mild. In 3 samples we observed deposits of immunocomplexes (IgG+), complement (C3+) or fibrinogen by immunofluorescence. These patients showed creatinine values above 4 mg/dl. There were no statistically significant differences in renal histology between groups (p: 0.091).

There was no association between hypocomplementemia and other organic damage or laboratory values.

Mortality rate was 18% (16/87), without differences between groups (p: 0.300).

Conclusion: Hypocomplementemia was associated with increased renal damage: decreased glomerular filtrate and greater values of proteinuria; as reported in the literature. We did not find any other statistically significant difference between groups.


Disclosure: L. García, None; C. E. Pena, None; M. Pera, None; M. Garcia, None; V. Arturi, None; V. Nagua, None; R. Aguila Maldonado, None; A. C. Costi, None; A. Testi, None; A. Vulcano, None; P. Sansinanea, None; M. Mamberti, None; M. E. Bruzzone, None; C. Barabani, None; J. Salomone, None.

To cite this abstract in AMA style:

García L, Pena CE, Pera M, Garcia M, Arturi V, Nagua V, Aguila Maldonado R, Costi AC, Testi A, Vulcano A, Sansinanea P, Mamberti M, Bruzzone ME, Barabani C, Salomone J. Increased Renal Damage in Hypocomplementemic Patients with ANCA- Associated Vasculitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/increased-renal-damage-in-hypocomplementemic-patients-with-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-renal-damage-in-hypocomplementemic-patients-with-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology